Deep Track Capital, LP Cytokinetics Inc Transaction History
Deep Track Capital, LP
- $2.27 Billion
- Q4 2024
A detailed history of Deep Track Capital, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Deep Track Capital, LP holds 2,500,000 shares of CYTK stock, worth $109 Million. This represents 5.18% of its overall portfolio holdings.
Number of Shares
2,500,000
Previous 629,906
296.88%
Holding current value
$109 Million
Previous $33.3 Million
253.59%
% of portfolio
5.18%
Previous 1.23%
Shares
4 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
114MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$640 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$520 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$469 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$269 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$124 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.11B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...